Pro-inflammatory cytokine antagonists can effectively block the inflammatory response and bone resorption process of peri-implantitis by specifically inhibiting the activity of key inflammatory mediators such as IL-1β and tumor necrosis factor-α. This evidence concerns the gene IL1B and Peri-Implantitis.